tykhr
sign in
free sign up
Syros Pharmaceuticals Inc
Biotechnology
Healthcare
SYRS
27.91 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
7.64
52 week high
7.84
high
8.17
52 week low
2.13
low
7.51
growth
64.36 %
previous Close
7.79
P/E ratio
-6
market cap
77.65 M
div yield
0
usd
Jun 2023
qoq
revenue
2.83 M
-4.10 %
net incoming
-36.26 M
-52.41 %
eps
-1.30 %
-52.94 %
eps surprise
-15.04 %
net profit margin
-1279.84 %
-474.00 %
operating incoming
-34.00 M
-2.37 %
net change in cash
10.68 M
117.03 %
cash on hand
115 M
10.19 %
cost of revenue
0.00 %
top